NCT07570654 Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06247839 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder Status RECRUITING Phase PHASE3
NCT05733546 A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05624268 Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05481736 Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study Status COMPLETED Phase PHASE2
NCT05381974 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD Status WITHDRAWN Phase PHASE2
NCT05312151 The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder Status COMPLETED Phase PHASE2
NCT05220410 The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation Status COMPLETED Phase PHASE2
NCT04739865 The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT04661514 Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy Status COMPLETED Phase PHASE2
NCT04656301 Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Status COMPLETED Phase PHASE2
NCT04519957 Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU) Status COMPLETED Phase N/A
NCT04433858 An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04433845 The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. Status UNKNOWN Phase PHASE2
NCT03775200 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression Status COMPLETED Phase PHASE2